Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment

American Heart Journal

Volumn 146, Issue 1, 2003, Pages 99-105

  Murtagh, Blaithnead ^a   Higano, Stuart ^a   Lennon, Ryan ^b   Mathew, Verghese ^a   Holmes Jr , David R ^a   Lerman, Amir ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; HYPEREMIA; HYPERTENSION; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; RISK FACTOR;

EID: 0038160839     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00120-0     Document Type: Article

References (33)

1. Pijls NHJ, De Bruyne B. Coronary pressure measurement and fractional flow reserve. Heart 1998;80:539-42.
2. Kern MJ, De Bruyne B. From research to clinical practice: current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory. J Am Coll Cardiol 1997;30:613-20.
3. Donogue TJ, Kern MJ. Assessing the hemodynamic significance of coronary artery stenoses: analysis of translesional pressure-flow velocity relations in patients. J Am Coll Cardiol 1993;22:449-58.
4. Pijls NHJ, De Bruyne B. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. New Engl J Med 1996;334:1703-8.
5. Pijls NHJ, van Son JAM. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenoses severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993;86:1354-67.
6. De Bruyne B, Baudhuin T. Coronary flow reserve calculated from pressure measurements in humans: validation with positron emission tomography. Circulation 1994;89:1013-22.
7. De Bruyne B, Paulus WJ. Rationale and application of coronary transstenotic pressure gradient measurements. Catheter Cardiovasc Diagn 1994;33:250-61.
8. Pijls NHJ, Van Gelder B. Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenoses on myocardial blood flow. Circulation 1995;92:3183-93.
9. De Bruyne B, Bartunek J. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 1995;92:39-46.
10. Fearon WF, Takagi A, Jeremias A, et al. Use of FFR to access the functional significance of intermediate coronary stenoses. Am J Cardiol 2000;86:1013-4.
11. Miller DD, Donohue TJ. Myocardial imaging: correlation of pharmacological technetium-99-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation 1994;89:2150-60.
12. Bartunek J, van Schuerbeeck E, De Bruyne B. Comparison of exercise electrocardiography and dobutamine echocardiography with invasively assessed myocardial FFR in evaluation of severity of coronary arterial narrowing. Am J Cardiol 1997;79:478-81.
13. Chamuleau SA, Meuwissen M, van Eck-Smith BL, et al. Fractional flow reserve, absolute and relative coronary blood flow velocity reserve in relation to the results of technetium-99m sestamibi single-photon emission computed tomography in patients with two-vessel coronary artery disease. J Am Coll Cardiol 2001;37:1316-22.
14. De Bruyne B, Bartunek J. Simultaneous coronary pressure and flow velocity measurements in humans. Circulation 1996;94:1842-9.
15. Di Segni E, Higano ST, Rihal CS, et al. Incremental doses of intra-coronary adenosine for the assessment of coronary velocity reserve for clinical decision making. Catheter Cardiovasc Interv 2001;54:34-40.
16. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974;34:48-55.
17. Lamm C, Dohnal M. High-fidelity translesional pressure gradients during percutaneous transluminal coronary angioplasty: correlation with quantitative coronary angiography. Am Heart J 1993;126:66-75.
18. Serruys PW, DiMario C. Intracoronary pressure and flow velocity with sensor-tip guidewires: a new methodologic approach for assessment of coronary hemodynamics before and after coronary interventions. Am J Cardiol 1993;71:41-53D.
19. van der Voort PH, van Hagen E, Hendrix G, et al. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve. Cathet Cardiovasc Diagn 1996;39:20-125.
20. Wilson RF, Wyche K. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82:1595-606.
21. Rembert JC, Boyd LM, Watkinson WP, et al. Effect of adenosine on transmural myocardial blood flow distribution in the awake dog. Am J Physiol 1980;239:H7-13.
22. Jeremias A, Filardo SD. Effects of intravenous and intracoronary adenosine 5 [prime]-triphosphate as compared with adenosine on coronary bloodflow and pressure dynamics. Circulation 2000;10:318-28.
23. Zijlstra F, Juilliere Y. Value and limitations of intracoronary adenosine for the assessment of coronary flow reserve. Catheter Cardiovasc Diagnosis 1988;15:76-80.
24. Pijls NHJ, Kern MJ. Practice and potential pitfalls of coronary pressure measurement. Catheter Cardiovasc Interv 2000;49:1-16.
25. Billinger M, Seiler C, Fleisch M, et al. Underestimation of "true" coronary flow reserve by adenosine (abstract)? J Am Coll Cardiology 1999;33:46A.
26. Jermias A, Whitbourn RJ, Filardo SD, et al. Adequacy of intra-coronary adenosine versus intravenous adenosine-induced maximal coronary hyperemia for FFR measurement. Am Heart J 2000;140:651-7.
27. Werner GS, Ferrai M, Richartz BM. Microvascular dysfunction in chronic total coronary occlusion. Circulation 2001;104:1129-34.
28. Brush JE Jr, Cannon RO III, Schenke WH, et al. Angina due to coronary microvasculature disease in hypertensive patients without left ventrlcular hypertrophy. New Engl J Med 1988;319:1302-7.
29. Uren NG, Crake T, Lefroy DC, et al. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. New Engl J Med 1994;331:222-7.
30. Nahser PJ, Brown RE, Oskarssson H, et al. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diobetes mellitus. Circulation 1995;91:635-40.
31. De Bruyne B, Pijls NHJ, Bartunek J, et al. FFR in patients with prior myocardial infarction. Circulation 2001;104:157-62.
32. Shalman E, Barak C, Dgany E, et al. Pressure-based simultaneous CFR and FFR measurements: understanding the physiology of a stenosed vessel. Comput Biol Med 2001;31:353-63.
33. De Bruyne B, Pijls NHJ, Smith L, et al. Coronary thermodilution to access flow reserve. Circulation 2001;104:2003-6.